Replies to post #300843 on Amarin Corp Plc (AMRN)

[couldbebetter]

Kiwi, As to LBL's post here is my take:

1. Stock price today is at the liquidation value of assets.
2. Price gives zero value to Europe, Canada, China, US, and ROW.
3. BB have not sold. Why?
4. JT and BOD "must" have a plan.
5. JT stated last week about holding open the option of "doing something
with a larger company." What could JT mean here? Baking Cookies?
Obviously the only thing he could mean is a BO by BP.
6. The stock market is treating AMRN stock as if it is going out of
business...not a GIA or BO candidate.
7. What a BP could do with Vascepa is make it into a world class
Mega-Blockbuster drug...even if they cut the price down to
$1000 a year or about $80 a month. The KEY may be for the BP
to tie-up several years worth of feedstock at the lowest cost
to lock out other users including generics and supplements.
8. BP would (still) have the opportunity to make Vascepa into a
high quality, low cost, high volume, exceedingly effective
medication it should be. BP can do this! JT cannot!
9. Vascepa must get into the hands of BP to make it into a great drug!
10. JT Must "GO AWAY!"

[Will Lar]

I agree with these counter balancing points.

Nothing happens so far is because generics haven't launched.